Effect of subclinical infection on maintaining immunity against measles in vaccinated children in West Africa (Q43719943)

26 November 2017

title

Effect of subclinical infection on maintaining immunity against measles in vaccinated children in West Africa (English)

1 reference

26 November 2017

0 references

1 reference

2

1 reference

26 November 2017

F Simondon

6

0 references

author name string

H C Whittle

1

1 reference

26 November 2017

B Samb

3

1 reference

26 November 2017

H Jensen

4

1 reference

26 November 2017

J Bennett

5

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 January 1999

1 reference

26 November 2017

1 reference

26 November 2017

volume

353

1 reference

26 November 2017

issue

9147

1 reference

26 November 2017

page(s)

98-102

1 reference

Further-attenuated measles vaccine: characteristics and use.

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2902364-2

7 January 2021

Measles antibody: reevaluation of protective titers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2902364-2

7 January 2021

Measles outbreak in a fully immunized secondary-school population

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2902364-2

7 January 2021

Decline in measles case fatality ratio after the introduction of measles immunization in rural Senegal

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2902364-2

7 January 2021

Measles and pertussis in developing countries with good vaccine coverage

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2902364-2

7 January 2021

Assessing vaccine efficacy in the field. Further observations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2902364-2

7 January 2021

Trial of high-dose Edmonston-Zagreb measles vaccine in the Gambia: antibody response and side-effects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2902364-2

7 January 2021

Protective efficacy of high-titre measles vaccines administered from the age of five months: a community study in rural Senegal.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2902364-2

7 January 2021

Role of Schools in the Transmission of Measles In Rural Senegal: Implications for Measles Control In Developing Countries

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2902364-2

7 January 2021

Child mortality after high-titre measles vaccines: prospective study in Senegal

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2902364-2

7 January 2021

Pattern of exposure and measles mortality in Senegal

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2902364-2

7 January 2021

Seroconversions in unvaccinated infants: further evidence for subclinical measles from vaccine trials in Niakhar, Senegal.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2902364-2

7 January 2021

Measles incidence, vaccine efficacy, and mortality in two urban African areas with high vaccination coverage

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2902364-2

7 January 2021

Clustering of haemagglutinin gene sequences of measles viruses isolated in the Gambia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2902364-2

7 January 2021

Temporal and geographical distribution of measles virus genotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2902364-2

7 January 2021

Gamma-globulin and acquired immunity to human malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2902364-2

7 January 2021

Secondary failure rates of measles vaccines: a metaanalysis of published studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2902364-2

7 January 2021

Overcrowding and intensive exposure as determinants of measles mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2902364-2

7 January 2021

10.1016/S0140-6736(98)02364-2

Identifiers

DOI

1 reference

26 November 2017

1 reference